{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/heart-failure-chronic/how-up-to-date-is-this-topic/update/","result":{"pageContext":{"chapter":{"id":"4c4375f1-a348-5b99-b895-f04a15c64791","slug":"update","fullItemName":"Update","depth":2,"htmlHeader":"<!-- begin field 9c6bf131-4221-420e-b52b-3eb6bdf28dff --><h2>Update</h2><!-- end field 9c6bf131-4221-420e-b52b-3eb6bdf28dff -->","summary":null,"htmlStringContent":"<!-- begin item b3f8d235-4822-45b4-bd25-b9d26ba82eca --><!-- end item b3f8d235-4822-45b4-bd25-b9d26ba82eca -->","topic":{"id":"3a35207f-30ea-5eca-bfcf-dff091a73359","topicId":"fdc42e20-2c4b-45ed-9093-6c2d4bde6e4d","topicName":"Heart failure - chronic","slug":"heart-failure-chronic","lastRevised":"Last revised in January 2017","chapters":[{"id":"77c928c1-46d0-58c1-ba79-6015f89bc48a","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"f0aa9151-9d10-566e-85ec-6ccefed25f20","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"c036596d-f29d-5486-822a-b46af76451d7","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"fd5e8a95-3e97-5ec2-98ae-5a10c2373213","slug":"changes","fullItemName":"Changes"},{"id":"4c4375f1-a348-5b99-b895-f04a15c64791","slug":"update","fullItemName":"Update"}]},{"id":"7472c037-35d4-5fd2-bba6-dfd891ade816","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"cde936d1-3945-5bc6-8c22-9106d78cf77c","slug":"goals","fullItemName":"Goals"},{"id":"bfa0b8d3-fac0-500e-a762-f719dc619f1b","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"5d2cf55e-1ae2-5000-9c94-e9c86d26a824","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"c8203a8a-fc22-5378-b33b-34ddf818dea5","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"4b5e4f72-1a3e-531c-be82-a1919603c934","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"c206f1b2-7616-587d-b3bf-b65ba5b5adb4","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"ab1d2b81-1f2b-55e5-abf0-c14e4ae4a78d","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"cb83ac3c-e97e-5cab-acca-5abebc7bd6b1","slug":"definition","fullItemName":"Definition"},{"id":"66c995b7-504c-5510-9e77-1a9b27ee7dca","slug":"causes","fullItemName":"Causes"},{"id":"88dbdf7b-53b7-5952-97b9-2312c0a2ce63","slug":"prevalence","fullItemName":"Prevalence"},{"id":"a0b16521-d808-5dfd-89dc-64fc6ae7f6ce","slug":"prognosis","fullItemName":"Prognosis"},{"id":"262fb896-526d-594f-8142-98c291781249","slug":"complications","fullItemName":"Complications"}]},{"id":"72804751-fb0c-5a96-85b5-982feb950f16","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"8b798e41-3fbe-5027-9365-da41e1c98e93","slug":"when-to-suspect","fullItemName":"When to suspect"},{"id":"e6498250-f313-5ea2-a1e8-2d0342823c39","slug":"how-to-manage-suspected","fullItemName":"How to manage suspected"},{"id":"74e553b4-7cb8-52a6-a573-8715f63a2ba8","slug":"how-to-assess","fullItemName":"How to assess"},{"id":"53bf7ae0-a1d0-5fae-9d3b-57cbc6f03bb8","slug":"what-else-could-it-be","fullItemName":"What else could it be"}]},{"id":"38c5edc8-6b4a-5e71-bb70-cf0a09389ae0","fullItemName":"Management","slug":"management","subChapters":[{"id":"97a0eca4-a290-588b-a16a-bc95b93cd893","slug":"confirmed-heart-failure-with-reduced-ejection-fraction","fullItemName":"Scenario: Confirmed heart failure with reduced ejection fraction"},{"id":"34ff8094-815a-55b7-9edd-49f3ac636471","slug":"confirmed-heart-failure-with-preserved-ejection-fraction","fullItemName":"Scenario: Confirmed heart failure with preserved ejection fraction"},{"id":"28fde475-ef24-59d3-9171-a8d59a3fb149","slug":"end-stage-heart-failure","fullItemName":"Scenario: End-stage heart failure"},{"id":"c587255a-a47e-57a1-bc4d-967753c38d11","slug":"information-advice-follow-up-referral","fullItemName":"Scenario: Information and advice, follow-up, and referral"}]},{"id":"e82d6013-cb43-59d5-9e2e-0af05276fb9d","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"8fd96acc-3fa6-528b-9351-49db836228b1","slug":"managing-aiiras","fullItemName":"Managing AIIRAs"},{"id":"06c9d276-e5ea-5a0b-9ff4-343f10034763","slug":"managing-ace-inhibitors","fullItemName":"Managing ACE-inhibitors"},{"id":"df53e9a8-07f8-5d37-94cf-78e99d4c8216","slug":"managing-beta-blockers","fullItemName":"Managing beta-blockers"},{"id":"faad170c-d1ee-59ad-9847-f7afdda6d9b9","slug":"managing-diuretics","fullItemName":"Managing diuretics"},{"id":"a3ea6beb-7ee3-586c-9985-47c20d804195","slug":"covid-19","fullItemName":"COVID-19"}]},{"id":"7b9c5d56-39f1-53df-b1f9-2dcc5bbb498a","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"df3b6e0c-ca5a-59eb-93e6-4b4370389ed2","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"7a756ff1-7152-5bdd-92ca-7f9e67351dd9","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"f5e1707e-f2a9-54e0-92fa-71beb41e38af","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"691681cc-720f-5242-9fb3-3040860027e7","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"7f39ec24-cb87-5fba-ae6b-6fb2d9538859","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"4afe2b30-f837-53a3-88df-7b1913a54081","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"d4dace55-ef1c-5675-bdbe-180512d549fa","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"c036596d-f29d-5486-822a-b46af76451d7","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?"},"subChapters":[{"id":"6a8ea0b2-ffa5-57c8-ac9d-f82063714af3","slug":"new-evidence","fullItemName":"New evidence","depth":3,"htmlHeader":"<!-- begin field 0f9b9a2a-3a87-47ee-8e13-194540cfae10 --><h3>New evidence</h3><!-- end field 0f9b9a2a-3a87-47ee-8e13-194540cfae10 -->","summary":null,"htmlStringContent":"<!-- begin item f3227730-97ed-40da-b26d-d8b32625df39 --><!-- begin field 012bf596-17c1-4e1a-90d2-e6b9bca0a64e --><h3>Evidence-based guidelines</h3><!-- end field 012bf596-17c1-4e1a-90d2-e6b9bca0a64e --><!-- begin field fe9882f2-8f23-45de-94be-03414b0524b3 --><ul><li>British Society for Heart Failure (2017) <em>National Heart Failure Audit Report: April 2015 to March 2016</em>. <a href=\"http://www.ucl.ac.uk/\" data-hyperlink-id=\"fbefdeaa-5954-4284-84bb-a931009918cc\">www.ucl.ac.uk</a> [<a href=\"http://www.ucl.ac.uk/nicor/audits/heartfailure/documents/annualreports/annual-report-2015-6-v8.pdf\" data-hyperlink-id=\"06993ea0-1d95-41b8-966a-a9310099194a\">Free Full-text</a>]</li><li>Yancy, C., Jessup, M., Bozkurt, B., et al. (2017) 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. <em>Circulation</em> <strong>136</strong> e137-e161. [<a href=\"http://circ.ahajournals.org/content/136/6/e137\" data-hyperlink-id=\"1a17e882-bbf1-493e-8bce-a93100991955\">Free Full-text</a>]</li><li>SIGN (2017) <em>Cardiac rehabilitation</em>. Scottish Intercollegiate Guidelines Network. <a href=\"https://www.sign.ac.uk/\" data-hyperlink-id=\"25f62ea2-641e-44d9-a279-a93100991b5d\">www.sign.co.uk</a> [<a href=\"http://www.sign.ac.uk/sign-150-cardiac-rehabilitation.html\" data-hyperlink-id=\"c97f778f-e4d7-42bb-94fa-a93100991e82\">Free Full-text</a>]</li><li>SIGN (2017) <em>Risk estimation and the prevention of cardiovascular disease</em>. Scottish Intercollegiate Guidelines Network. <a href=\"https://www.sign.ac.uk/\" data-hyperlink-id=\"6ab5bc4d-403c-496a-9f39-a93100991e87\">www.sign.co.uk</a> [<a href=\"http://www.sign.ac.uk/sign-149-risk-estimation-and-the-prevention-of-cardiovascular-disease.html\" data-hyperlink-id=\"69f808b5-f4e3-4360-9c6b-a93100991e90\">Free Full-text</a>]</li></ul><!-- end field fe9882f2-8f23-45de-94be-03414b0524b3 --><!-- begin field ff7a23ca-16a8-4121-b547-af82ac7effe4 --><h3>HTAs (Health Technology Assessments)</h3><!-- end field ff7a23ca-16a8-4121-b547-af82ac7effe4 --><!-- begin field 613135f5-51fb-4706-9a89-a62866a4cb9f --><p>No new HTAs since 1 January 2017.</p><!-- end field 613135f5-51fb-4706-9a89-a62866a4cb9f --><!-- begin field 6db71770-ce4d-49fc-ab09-8c64ec6cecea --><h3>Economic appraisals</h3><!-- end field 6db71770-ce4d-49fc-ab09-8c64ec6cecea --><!-- begin field 8f3e5aeb-1c6f-4786-9f0b-7eb46fd6e673 --><p>No new economic appraisals relevant to England since 1 January 2017.</p><!-- end field 8f3e5aeb-1c6f-4786-9f0b-7eb46fd6e673 --><!-- begin field e5b2ddff-b3d0-478c-a1b1-6d002d5ad23f --><h3>Systematic reviews and meta-analyses</h3><!-- end field e5b2ddff-b3d0-478c-a1b1-6d002d5ad23f --><!-- begin field 9f1737dd-c549-4a91-8e1b-cacc4d406793 --><ul><li>BMJ (2018) <em>Cardiovascular outcomes associated with canagliflozin versus other non-gliflozin antidiabetic drugs: population based cohort study</em>. British Medical Journal 2018;360:k119</li><li>Rossignol, P., Hernandez, A., Solomon, S., et al. (2019) <em>Heart failure drug treatment. </em>The Lancet. <a href=\"https://www.thelancet.com/\" data-hyperlink-id=\"8e49f9dc-c921-4dfe-9222-aa1401024200\">www.thelancet.com</a> [<a href=\"https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(18)31808-7/fulltext\" data-hyperlink-id=\"33b3d3ef-d5a7-4af9-9aa2-aa1401024cd4\">Free Full-text</a>]</li></ul><!-- end field 9f1737dd-c549-4a91-8e1b-cacc4d406793 --><!-- begin field 53151396-2a5e-49ae-9dc4-9ce916803be4 --><h3>Primary evidence</h3><!-- end field 53151396-2a5e-49ae-9dc4-9ce916803be4 --><!-- begin field 22676bd9-4fba-408b-9c38-1024482cc640 --><p>No new primary evidence published since 1 January 2017.</p><!-- end field 22676bd9-4fba-408b-9c38-1024482cc640 --><!-- end item f3227730-97ed-40da-b26d-d8b32625df39 -->","subChapters":[]},{"id":"1caf7bff-195a-58b5-ac15-d8a20ce10860","slug":"new-policies","fullItemName":"New policies","depth":3,"htmlHeader":"<!-- begin field caba34f8-1eba-4b65-b01b-31ea82b8a768 --><h3>New policies</h3><!-- end field caba34f8-1eba-4b65-b01b-31ea82b8a768 -->","summary":null,"htmlStringContent":"<!-- begin item b87da2c3-b485-4a05-9faf-746e475d6da9 --><!-- begin field d2785737-ef9e-4850-86c9-fbfbf67011cc --><p>No new national policies or guidelines since 1 January 2017.</p><!-- end field d2785737-ef9e-4850-86c9-fbfbf67011cc --><!-- end item b87da2c3-b485-4a05-9faf-746e475d6da9 -->","subChapters":[]},{"id":"7d01461c-0958-5309-a274-593f547b589c","slug":"new-safety-alerts","fullItemName":"New safety alerts","depth":3,"htmlHeader":"<!-- begin field 8fafcef6-6fcf-4ab6-9f1f-77c21af629a0 --><h3>New safety alerts</h3><!-- end field 8fafcef6-6fcf-4ab6-9f1f-77c21af629a0 -->","summary":null,"htmlStringContent":"<!-- begin item b7921afd-321b-438c-a200-7c2321ade579 --><!-- begin field b62f598b-de6a-410f-80f4-2263e60ff058 --><p>No new safety alerts issued since 1 January 2017.</p><!-- end field b62f598b-de6a-410f-80f4-2263e60ff058 --><!-- end item b7921afd-321b-438c-a200-7c2321ade579 -->","subChapters":[]},{"id":"df7a4071-f6b9-5f35-a09d-27db214aaaa1","slug":"changes-in-product-availability","fullItemName":"Changes in product availability","depth":3,"htmlHeader":"<!-- begin field 5cc2e69d-803b-4dc1-bbb1-cedc11a1eebc --><h3>Changes in product availability</h3><!-- end field 5cc2e69d-803b-4dc1-bbb1-cedc11a1eebc -->","summary":null,"htmlStringContent":"<!-- begin item 2e8e7bca-d7b3-4180-aed2-4a311e664458 --><!-- begin field 77c24a45-e1f5-4540-8162-ee4cdac3a9b7 --><ul><li>Dapagliflozin license extension for use in symptomatic chronic heart failure with reduced ejection fraction in adults. Dapagliflozin has not been studied for the treatment of heart failure in patients with type 1 diabetes mellitus, therefore not recommended in this patient cohort. See more <a href=\"https://www.medicines.org.uk/emc/product/2865/smpc\" data-hyperlink-id=\"9f816b13-725e-4cf5-966f-ac7900bf23da\">here</a>.</li></ul><!-- end field 77c24a45-e1f5-4540-8162-ee4cdac3a9b7 --><!-- end item 2e8e7bca-d7b3-4180-aed2-4a311e664458 -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}